Finance

Lists
Q2 2027 earnings • released • EPS miss -1.70% • Revenue miss -14.45%
See results
MAXHEALTH:NSE
Max Healthcare Institute Ltd
₹884.75
+2.88%
(+24.75) 1D
Nov 2, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MAXHEALTH...
Open
₹863.80
High
₹905.50
Low
₹863.80
Mkt. cap
861.15B
Avg. vol.
3.46M
Volume
7.04M
Dividend
0.23%
Quarterly dividend
₹0.50
Ex-dividend date
Jul 3, 2026
P/E ratio
59.06
52-wk high
₹1,185.40
52-wk low
₹797.00
EPS
₹14.98
No. of employees
16K
Open
₹863.80
High
₹905.50
Low
₹863.80
Mkt. cap
861.15B
Avg. vol.
3.46M
Volume
7.04M
Dividend
0.23%
Quarterly dividend
₹0.50
Ex-dividend date
Jul 3, 2026
P/E ratio
59.06
52-wk high
₹1,185.40
52-wk low
₹797.00
EPS
₹14.98
No. of employees
16K
News stories
From web sources and news partners
Profile
Max Healthcare Institute Limited is an Indian for-profit private hospital chain headquartered in Delhi. As of June 2025, Max Healthcare operates 22 hospitals, with a total of over 5,000 beds, primarily in North India. Max Healthcare also operates the Max Lab pathology and Max@Home home medical services divisions. Wikipedia
About Max Healthcare Institute Ltd
CEO-
Employees16.3K
Founded2001
Headquarters-
SectorHealth care provider
Last report
Nov 3, 2026
Fiscal period
Q2 2027
₹4.24 / ₹4.31
-1.70%miss
Revenue / Est. (INR)
25.69B / 30.03B
-14.45%miss
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
20.68B
21.43B
23.66B
25.69B
Cost of goods sold
7.81B
7.80B
9.02B
9.15B
Cost of revenue
7.81B
7.80B
9.02B
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.42B
4.73B
5.23B
5.64B
Operating expense
8.60B
8.77B
9.98B
10.81B
Total operating expenses
16.40B
16.57B
18.99B
19.95B
Operating income
4.27B
4.86B
4.67B
5.74B
Other non operating income
155.00M
-105.50M
50.40M
-
EBT including unusual items
3.65B
4.65B
4.36B
5.41B
EBT excluding unusual items
4.13B
4.58B
4.36B
5.41B
Income tax expense
636.20M
1.22B
1.13B
1.26B
Effective tax rate
17.45%
26.34%
25.98%
-
Other operating expenses
3.06B
2.81B
3.43B
3.79B
Net income
3.01B
3.42B
3.22B
4.15B
Net profit margin
14.55%
15.97%
13.63%
16.15%
Earnings per share
3.50
3.50
3.30
4.24
Interest and investment income
298.80M
321.50M
354.80M
324.40M
Interest expense
-596.70M
-466.00M
-710.00M
-738.40M
Net interest expenses
-297.90M
-144.50M
-355.20M
-414.00M
Depreciation and amortization charges
1.11B
1.23B
1.32B
1.38B
EBITDA
5.03B
5.81B
5.62B
7.09B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps